Evert M. Noordijk

6.7k total citations · 1 hit paper
55 papers, 4.3k citations indexed

About

Evert M. Noordijk is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Evert M. Noordijk has authored 55 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 25 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Evert M. Noordijk's work include Lymphoma Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (16 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Evert M. Noordijk is often cited by papers focused on Lymphoma Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (16 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Evert M. Noordijk collaborates with scholars based in Netherlands, France and Belgium. Evert M. Noordijk's co-authors include J. Hermans, Charles J. Vecht, Ronald Brand, George W. Padberg, J. H. C. Voormolen, J. T. J. Tans, A.R. Wattendorff, Berthe M.P. Aleman, Patrice Carde and José Thomas and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Evert M. Noordijk

54 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery

1993 763 citations Charles J. Vecht, Evert M. Noordijk et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evert M. Noordijk Netherlands	31	2.3k	1.7k	1.5k	929	815	55	4.3k
Bouthaina S. Dabaja United States	30	820 0.4×	1.5k 0.9×	1.2k 0.8×	351 0.4×	309 0.4×	144	3.1k
Richard S. Cox United States	35	1.3k 0.6×	680 0.4×	749 0.5×	374 0.4×	388 0.5×	77	3.6k
Augustinus D. G. Krol Netherlands	28	2.2k 1.0×	1.3k 0.8×	1.0k 0.7×	208 0.2×	249 0.3×	77	4.5k
Hélène Pacquement France	36	1.4k 0.6×	1.1k 0.6×	1.1k 0.7×	339 0.4×	221 0.3×	108	4.1k
J. Robert Cassady United States	24	705 0.3×	1.2k 0.7×	764 0.5×	334 0.4×	196 0.2×	42	2.9k
Jean-François Cordier France	41	6.1k 2.7×	653 0.4×	405 0.3×	1.2k 1.3×	1.2k 1.4×	113	7.4k
Michael Schaapveld Netherlands	37	1.2k 0.5×	1.4k 0.8×	2.2k 1.5×	127 0.1×	632 0.8×	155	5.7k
Elo Andersen Denmark	38	1.2k 0.5×	800 0.5×	1.6k 1.1×	497 0.5×	397 0.5×	145	4.9k
R. Somers Netherlands	26	1.2k 0.5×	1.7k 1.0×	1.1k 0.8×	447 0.5×	336 0.4×	65	2.9k
José Thomas Belgium	38	1.2k 0.5×	3.3k 1.9×	1.5k 1.0×	1.1k 1.1×	188 0.2×	77	4.3k

Countries citing papers authored by Evert M. Noordijk

Since Specialization

Citations

This map shows the geographic impact of Evert M. Noordijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evert M. Noordijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evert M. Noordijk more than expected).

Fields of papers citing papers by Evert M. Noordijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evert M. Noordijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evert M. Noordijk. The network helps show where Evert M. Noordijk may publish in the future.

Co-authorship network of co-authors of Evert M. Noordijk

This figure shows the co-authorship network connecting the top 25 collaborators of Evert M. Noordijk. A scholar is included among the top collaborators of Evert M. Noordijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evert M. Noordijk. Evert M. Noordijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Putter, Hein, Harry Bartelink, Jaime S. Cardoso, et al.. (2012). Long-term cosmetic changes after breast-conserving treatment of patients with stage I–II breast cancer and included in the EORTC ‘boost versus no boost’ trial. Annals of Oncology. 23(10). 2591–2598. 63 indexed citations

Belt‐Dusebout, Alexandra W. van den, Berthe M.P. Aleman, Marie L. De Bruin, et al.. (2009). Roles of Radiation Dose and Chemotherapy in the Etiology of Stomach Cancer as a Second Malignancy. International Journal of Radiation Oncology*Biology*Physics. 75(5). 1420–1429. 63 indexed citations

Willemze, Annemiek, Ronald B. Geskus, Evert M. Noordijk, et al.. (2007). HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI. Bone Marrow Transplantation. 40(4). 319–327. 9 indexed citations

Kaaij, Marleen A. E. van der, Natacha Heutte, Nolwenn Le Stang, et al.. (2007). Gonadal Function in Males After Chemotherapy for Early-Stage Hodgkin's Lymphoma Treated in Four Subsequent Trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Étude des Lymphomes de l'Adulte. Journal of Clinical Oncology. 25(19). 2825–2832. 57 indexed citations

Noordijk, Evert M., Patrice Carde, N. Dupouy, et al.. (2006). Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials. Journal of Clinical Oncology. 24(19). 3128–3135. 149 indexed citations

Noordijk, Evert M., José Thomas, Pauline Brice, et al.. (2005). First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin’s lymphoma (HL). Journal of Clinical Oncology. 23(16_suppl). 6505–6505. 76 indexed citations

Aleman, Berthe M.P., T. Girinsky, Richard W.M. van der Maazen, et al.. (2005). Quality control of involved-field radiotherapy in patients with advanced Hodgkin’s lymphoma (EORTC 20884). International Journal of Radiation Oncology*Biology*Physics. 63(4). 1184–1190. 18 indexed citations

Kuper‐Hommel, Marion, Simone Snijder, Maryska L.G. Janssen‐Heijnen, et al.. (2003). Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Annals of Hematology. 82(7). 397–404. 48 indexed citations

Scholten, Astrid N., Carien L. Creutzberg, Evert M. Noordijk, & Vincent T.H.B.M. Smit. (2002). Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system. International Journal of Radiation Oncology*Biology*Physics. 52(4). 1067–1074. 36 indexed citations

10.

Wondergem, Jan, et al.. (2001). Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy. Radiotherapy and Oncology. 58(3). 295–301. 23 indexed citations

11.

Noordijk, Evert M.. (1998). Radiotherapy in early stage Hodgkin’s disease: Principles and results of recent clinical trials. Annals of Oncology. 9. s63–s65. 2 indexed citations

12.

Meerwaldt, J.H., Patrice Carde, R. Somers, et al.. (1997). Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.. PubMed. 8 Suppl 1. 67–70. 11 indexed citations

13.

Krol, Augustinus D. G., J. Hermans, M Krámer, et al.. (1997). Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival. Cancer. 79(2). 390–397. 22 indexed citations

14.

Krol, Augustinus D. G., et al.. (1996). Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation?. International Journal of Radiation Oncology*Biology*Physics. 34(2). 297–302. 166 indexed citations

15.

Dubray, Bernard, et al.. (1995). Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation. Radiotherapy and Oncology. 36(3). 211–217. 58 indexed citations

16.

Noordijk, Evert M., Charles J. Vecht, Hanny Haaxma-Reiche, et al.. (1994). The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. International Journal of Radiation Oncology*Biology*Physics. 29(4). 711–717. 478 indexed citations

17.

Carde, Patrice, Anton Hagenbeek, M. Hayat, et al.. (1993). Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.. Journal of Clinical Oncology. 11(11). 2258–2272. 139 indexed citations

18.

Cosset, Jean‐Marc, M. Henry‐Amar, J.H. Meerwaldt, et al.. (1992). The EORTC trials for limited stage Hodgkin's disease. European Journal of Cancer. 28(11). 1847–1850. 47 indexed citations

19.

Sont, Jacob K., et al.. (1992). Increased risk of second cancers in managing Hodgkin's disease: the 20-year Leiden experience. Annals of Hematology. 65(5). 213–218. 19 indexed citations

20.

Cosset, Jean‐Marc & Evert M. Noordijk. (1989). 9th annual meeting of the european society for therapeutic radiology and oncology. Radiotherapy and Oncology. 16(4). 331–334. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact